As attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Saptak Chem and Business Limited reported zero revenue from operations for the third quarter and nine months ended December 31, 2025, with only Rs. 0.20 lakhs in other income. The company posted a net loss of Rs. 10.64 lakhs for Q3 FY26, widening from a loss of Rs. 0.42 lakhs in the same quarter last year, and a cumulative loss of Rs. 18.16 lakhs for the nine-month period. Total expenses of Rs. 10.84 lakhs in Q3 were driven mainly by other expenses (Rs. 8.80 lakhs) and employee costs (Rs. 2.04 lakhs). The paid-up equity share capital shows a reduction from Rs. 1073.23 lakhs to Rs. 107.32 lakhs, suggesting a possible share consolidation or capital restructuring. The statutory auditor issued an unqualified limited review report with no adverse observations.
The company remains operationally dormant with no business income, consistent quarterly losses are eroding shareholder value, and the sharp cut in share capital warrants clarification on whether this reflects a stock split reversal, capital reduction, or share buyback. Retail investors should treat this as a high-risk, non-revenue-generating stock until operations resume.